Retinoid regulation of human cathepsin D gene expression

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 5-6, 1996, Pages 283-291

  Sheikh, M Saeed ^a   Augereau, Patrick ^a   Chalbos, Dany ^a   Garcia, Marcel ^a   Rochefort, Henri ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; MESSENGER RNA; RETINOIC ACID;

ARTICLE; BREAST CANCER; CELL LINE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALE; PROMOTER REGION;

EID: 0343289247     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00267-7     Document Type: Article

References (20)

1. Rochefort H.: Cathepsin D in breast cancer. A tissue marker associated with metastasis. Eur. J. Cancer 28A (1992) 1780-1783
2. Spyratos F., Maudelonde T., Brouillet J. P., Brunet M., Defrenne A., Andrieu C., Hacene K., Desplaces A., Rouëssé J. and Rochefort H.: Cathepsin D: An independent prognostic factor for metastasis of breast cancer. Lancet 8672 (1989) 1115-1118.
3. Garcia M., Derocq D., Pujol P. and Rochefort H.: Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5 (1990) 1809-1814.
4. Liaudet E., Garcia M. and Rochefort H.: Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene 9 (1994) 1145-1154.
5. Cavaillès V., Garcia M. and Rochefort H.: Regulation of cathepsin D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol. Endocrinol. 3 (1989) 552-558.
6. Augereau P., Miralles F., Cavaillès V., Gaudelet C., Parker M. and Rochefort H.: Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8 (1994) 693-703
7. Redecker B., Horst M. and Hasilik A.: Calcitriol enhances transcriptional activity of lysozyme and cathepsin D genes in U937 promonocytes. Biochem. J. 262 (1989) 843-847.
8. Elangovan S. and Moulton B. C.: Progesterone and estrogen control of rates of synthesis of uterine cathepsin D. J. Biol. Chem. 255 (1980) 7474-7479.
9. Maudelonde T., Martinez P., Brouillet J. -P., Laffargue F., Pages A. and Rochefort H.: Cathepsin D in human endometrium: Induction by progesterone and potential value as a tumor marker. J. Clin. Endocrinol. Metab. 70 (1990) 115-121.
10. Sheikh M. S., Shao Z. -M., Li X. -S., Dawson M., Jetten A. M., Wu S., Conley B. A., Garcia M., Rochefort H. and Fontana J. A.: Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor -α acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem. 269 (1994) 21440-21447.
11. Chalbos D., Philips A., Galtier F. and Rochefort H.: Synthetic antiestrogens modulate induction of pS2 and cathepsin D messenger ribonucleic acid by growth factors and adenosine 3′, 5′-monophosphate in MCF7 cells. Endocrinology 133 (1993) 571-576.
12. Sheikh M. S., Shao Z. -M., Chen J. -C., Hussain A., Jetten A. M. and Fontana J. A.: Estrogen receptor-negative breast cancer cells transfected with the estrogcn receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell Biochem. 53 (1993) 394-404.
13. Feinberg A. P. and Vogelstein B.: A technique for radio labelling DNA restriction endonuclease fragments to high specific activity. Ann. Biochem. 132 (1989) 6-13.
14. Shao Z. -M., Sheikh M. S., Chen J. -C., Kute T., Aisner S., Schnaper L. and Fontana J. A.: Expression of the retinoic acid nuclear receptors (RARs) and retinoid X receptor (RXR) genes in estrogen receptor positive and negative breast cancer. Int. J. Oncol. 4 (1994) 859-863.
15. Titcomb M. W., Gottardis M. M., Pike J. W. and Allegretto E. A.: Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts. Mol. Endocrinol. 8 (1994) 870-877.
16. Giguère V.: Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signalling. Endocrine Rev. 15 (1994) 61-79.
17. Gudas L. J.: Retinoids, retinoid-responsive genes, cell differentiation and cancer. Cell Growth Differ. 3 (1992) 655-662.
18. Pfahl M.: Nuclear receptor: AP-1 interaction. Endocrine Rev. 14 (1993) 651-658.
19. II30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79 (1994) 107-117.
20. Cavaillès V., Dauvois S., Danielian P. S. and Parker M. G.: Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natn. Acad. Sci. 91 (1994) 10009-10013.